Differences in T cell-associated serum markers between ischemic cardiomyopathy and dilated cardiomyopathy
Authors:
Open Access
- 1 July 2024
- journal article
- research article
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 16 (7) , 4655-4665
Abstract
Background: Ischemic cardiomyopathy (ICM) and dilated cardiomyopathy (DCM) have similar clinical manifestations but differ in pathogenesis. We aimed to identify T cell-associated serum markers that can be used to distinguish between ICM and DCM. Methods: We identified differentially expressed genes (DEGs) with transcriptome sequencing data in GSE116250, and then conducted enrichment analysis of DEGs in the Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) databases. Protein-protein interaction (PPI) networks were used to analyze the relationship between T cells-related genes and identify hub genes. Enzyme-linked immunosorbent assay (ELISA) kits were used to detect T cell-associated proteins in serum, and receiver operating characteristic (ROC) curves were used to evaluate the diagnostic efficacy of these serum markers. Results: Using the limma package and Venn plots, we found that the non-failing donors (NFD) and DCM groups shared many of the same DEGs and DEGs-enriched functions compared to the ICM group, which were involved in T cell activation and differentiation, among other functions. Subsequently, the immune cell score showed no difference between NFD and DCM, but they were significantly different from ICM patients in CD8 T cells CD4 T cells memory resting and activated, T cells follicular helper, and M1 macrophage. After analyzing T cell-associated DEGs, it was found that 4 DEGs encoding secreted proteins were highly expressed in the ICM group compared with the NFD and DCM groups, namely chemokine (C-C motif) ligand 21 (CCL21), interleukin (IL)-1β, lymphocyte-activation gene 3 (LAG3), and vascular cell adhesion molecule-1 (VCAM-1). Importantly, the serum levels of CCL21, IL-1β, LAG3, and VCAM-1 in ICM patients were all significantly higher than those in DCM patients. The ROC curves showed that the area under the curve (AUC) values of serum CCL21, IL-1β, LAG3, and VCAM-1 were 0.775, 0.868, 0.934, and 0.903, respectively. Conclusions: We have identified four T cell-associated serum markers, CCL21, IL-1β, LAG3, and VCAM-1, as potential diagnostic serum markers that differentiate ICM from DCM.Keywords
This publication has 30 references indexed in Scilit:
- Cardiac dopamine D1 receptor triggers ventricular arrhythmia in chronic heart failureNature Communications, 2020
- Identification of candidate genes in ischemic cardiomyopathy by gene expression omnibus databaseBMC Cardiovascular Disorders, 2020
- Inflammatory Related Cardiovascular Diseases: From Molecular Mechanisms to Therapeutic TargetsCurrent Pharmaceutical Design, 2020
- Computed tomography coronary angiography – past, present and futureSingapore Medical Journal, 2020
- VCAM-1 Density and Tumor Perfusion Predict T-cell Infiltration and Treatment Response in Preclinical ModelsNeoplasia, 2019
- Dilated cardiomyopathy: from epidemiologic to genetic phenotypesJournal of Internal Medicine, 2019
- Dysfunctional and Proinflammatory Regulatory T-Lymphocytes Are Essential for Adverse Cardiac Remodeling in Ischemic CardiomyopathyCirculation, 2019
- Transcriptome analysis of human heart failure reveals dysregulated cell adhesion in dilated cardiomyopathy and activated immune pathways in ischemic heart failureBMC Genomics, 2018
- Stretch, Injury and Inflammation Markers Evaluation to Predict Clinical Outcomes After Implantable Cardioverter Defibrillator Therapy in Heart Failure Patients With Metabolic SyndromeFrontiers in Physiology, 2018
- Profiling Tumor Infiltrating Immune Cells with CIBERSORT2018